• Search History (Register)
  • MeSH Browser
  • [Clear]
    • English
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agency of Health Technology Assessment of Uruguay
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canada’s Drug Agency (CDA-AMC)
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Healthcare Quality Institute
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Regione Emilia Romagna
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [16861 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Oncotype DX in women and men with ER-positive, HER2-negative early stage breast cancer who are lymph node negative: a review of clinical effectiveness and guidelines
2014     NIHR Health Services and Delivery Research programme Implications for the NHS of inward and outward medical tourism: a policy and economic analysis using literature review and mixed-methods approaches
2014     NIHR Horizon Scanning Centre (NIHR HSC) Idelalisib (Zydelig) for relapsed chronic lymphocytic leukaemia – in combination with bendamustine and rituximab
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Tiotropium bromide
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Diabetes care for indigenous populations: a review of the clinical evidence and guidelines
2014     NIHR Health Services and Delivery Research programme Variations in outcome and costs among NHS providers for common surgical procedures: econometric analyses of routinely collected data
2014     NIHR Horizon Scanning Centre (NIHR HSC) Ipilimumab (Yervoy) for metastatic hormone-relapsed prostate cancer following docetaxel treatment and radiotherapy
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Digital tomosynthesis for the screening and diagnosis of breast cancer: diagnostic accuracy and guidelines
2014     NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness results from the randomised controlled Trial of Oral Mandibular Advancement Devices for Obstructive sleep apnoea hypopnoea (TOMADO) and long-term economic analysis of oral devices and continuous positive airway pressure
2014     NIHR Health Technology Assessment programme Afatinib for treating epidermal growth factor receptor mutation positive locally advanced or metastatic non-small cell lung cancer
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Bolused (vice infused) tranexamic acid in adults experiencing hemorrhagic shock: safety, patient benefits, and guidelines
2014     NIHR Health Services and Delivery Research programme The efficient use of the maternity workforce and the implications for safety and quality in maternity care: a population-based, cross-sectional study
2014     NIHR Horizon Scanning Centre (NIHR HSC) Lanreotide for unresectable, locally advanced or metastatic gastroenteropancreatic neuroendocrine tumours – first line
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Frequency of rescreening of patients negative for antibiotic resistant organisms: clinical evidence and guidelines
2014     NIHR Health Technology Assessment programme Eculizumab for treating atypical haemolytic uraemic syndrome
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Ocriplasmin (Jetrea - Alcon Canada Inc.) indication: symptomatic vitreomacular adhesion
2014     NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab for advanced melanoma – second or third line
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Intravenous administration of medications in home care settings: clinical evidence and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Clinical review report. Ocriplasmin (Jetrea - Alcon Canada Inc.) indication: symptomatic vitreomacular adhesion
2014     NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab for BRAF V600 mutation– negative advanced melanoma – first line
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Urine testing in long-term care: clinical and cost effectiveness
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacoeconomic review report. Ocriplasmin (Jetrea - Alcon Canada Inc.) indication: symptomatic vitreomacular adhesion
2014     NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab for BRAF V600 mutation-positive advanced melanoma – first line
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Continuous positive airway pressure compared with oral devices or lifestyle changes for the treatment of obstructive sleep apnea: a review of the clinical and cost-effectiveness
2014     NIHR Health Technology Assessment programme Can rapid integrated Polymerase Chain Reaction (PCR)-based diagnostics for Gastrointestinal pathogens improve routine hospital infection control practice? A diagnostic study
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Somatropin (Genotropin - Pfizer Canada Inc.) indication: Turner syndrome
2014     Health Quality Ontario (HQO) Testing vitamin B12 levels in neuropathy, alopecia, dizziness, and fatigue: a rapid review
2014     NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab with ipilimumab for advanced melanoma – first line
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Parent advisors in pediatric rehabilitation: clinical effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Clinical review report. Somatropin (Genotropin - Pfizer Canada Inc.) indication: Turner syndrome
2014     Health Quality Ontario (HQO) Preoperative consultation: a rapid review
2014     NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab for advanced or metastatic clear-cell renal cell carcinoma – second or third line
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Universal screening for antibiotic-resistant organisms in long-term care facilities: clinical effectiveness and guidelines
2014     NIHR Health Technology Assessment programme The clinical and cost effectiveness of brief intervention for excessive alcohol consumption among people attending sexual health clinics: a randomised controlled trial (SHEAR)
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacoeconomic review report. Somatropin (Genotropin - Pfizer Canada Inc.) indication: Turner syndrome
2014     Health Quality Ontario (HQO) Preoperative cardiac stress tests for noncardiac surgery: a rapid review
2014     NIHR Horizon Scanning Centre (NIHR HSC) Ramucirumab (Cyramza) in combination with docetaxel for locally advanced or metastatic non-small cell lung cancer – second line
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Linaclotide
2014     NIHR Health Technology Assessment programme Radium-223 dichloride for treating metastatic hormone relapsed prostate cancer with bone metastases
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacoeconomic review report. Somatropin (Genotropin - Pfizer Canada Inc.) indication: long-term treatment of children who have growth failure due to an inadequate secretion of endogenous growth hormone
2014     Health Quality Ontario (HQO) Preoperative resting echocardiography for noncardiac surgery: a rapid review
2014     NIHR Horizon Scanning Centre (NIHR HSC) Ramucirumab for metastatic colorectal cancer – second line
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Dexmedetomidine for sedation in the ICU or PICU: a review of cost-effectiveness and guidelines
2014     NIHR Health Technology Assessment programme Enzalutamide for the treatment of metastatic hormone relapsed prostate cancer previously treated with a docetaxel-containing regimen
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Clinical review report. Somatropin (Genotropin - Pfizer Canada Inc.) indication: long-term treatment of children who have growth failure due to an inadequate secretion of endogenous growth hormone
2014     Health Quality Ontario (HQO) Hemoglobin A1c testing in diabetes: a rapid review
2014     NIHR Horizon Scanning Centre (NIHR HSC) Tasquinimod for chemotherapy naïve, metastatic hormone-relapsed prostate cancer
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Autologous blood reinfusion system for orthopedic surgery: clinical and cost-effectiveness
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Somatropin (Genotropin - Pfizer Canada Inc.) indication: long-term treatment of children who have growth failure due to an inadequate secretion of endogenous growth hormone
2014     Institute of Health Economics (IHE) Effectiveness of screening for endemic antibiotic resistant organisms (AROs) in hospital settings
2014     NIHR Horizon Scanning Centre (NIHR HSC) TH-302 in combination with doxorubicin for locally advanced or metastatic, unresectable soft tissue sarcoma – first line
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Extracorporeal membrane oxygenation for acute respiratory failure: a review of the clinical effectiveness and guidelines
2014     NIHR Health Technology Assessment programme The effectiveness of collaborative care for people with memory problems in primary care: results of the CAREDEM case management modelling and feasibility study
2014     NIHR Horizon Scanning Centre (NIHR HSC) SpaceOAR® perirectal spacing system for prostate cancer radiation
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin D toxicity associated with different vitamin D dosing regimens: safety
2014     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Stem cell transplantation for biologic-resistant Crohn's disease
2014     NIHR Health Technology Assessment programme The opportunities and challenges of pragmatic point-of-care randomised trials using routinely collected electronic records: evaluations of two exemplar trials
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Clinical review report. Somatropin (Genotropin - Pfizer Canada Inc.) indication: growth hormone deficiency in adults
2014     NIHR Health Technology Assessment programme Can rapid integrated polymerase chain reaction-based diagnostics for gastrointestinal pathogens improve routine hospital infection control practice? A diagnostic study
2014     NIHR Horizon Scanning Centre (NIHR HSC) Macy catheter for rectal drug administration
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Extracorporeal membrane oxygenation for cardiac failure: a review of the clinical effectiveness and guidelines
2014     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Remote presence robots in telemedicine
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacoeconomic review report. Somatropin (Genotropin - Pfizer Canada Inc.) indication: growth hormone deficiency in adults
2014     NIHR Health Technology Assessment programme The SNAP trial: a randomised placebo-controlled trial of nicotine replacement therapy in pregnancy - clinical effectiveness and safety until 2 years after delivery, with economic evaluation
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Post-operative cerebrospinal fluid removal: guidelines
2014     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Ablative techniques for the treatment of localised prostate cancer
2014     NIHR Health Technology Assessment programme The SNAP trial: a randomised placebo-controlled trial of nicotine replacement therapy in pregnancy; effectiveness and safety until 2 years after delivery, with economic evaluation
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Lurasidone (Latuda - Sunovion Pharmaceuticals Inc.) indication: schizophrenia
2014     NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of cholecystectomy compared with observation/conservative management for preventing recurrent symptoms and complications in adults presenting with uncomplicated symptomatic gallstones or cholecystitis: a systematic review and economic evaluation
2014     NIHR Horizon Scanning Centre (NIHR HSC) CoVa™ Monitoring System for congestive heart failure
2014     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Opportunities and strategies to drive appropriate use of MRI in Austria
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Islet cell transplantation in patients with unstable diabetes: a review of clinical- and cost-effectiveness and guidelines
2014     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Theralite for treatment of renal failure in patients with multiple myeloma
2014     NIHR Health Technology Assessment programme Randomised controlled trial and health economic evaluation of the impact of diagnostic testing for influenza, respiratory syncytial virus and Streptococcus pneumoniae infection on the management of acute admissions in the elderly and high-risk 18- to 64-year olds
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Clinical review report. Lurasidone (Latuda - Sunovion Pharmaceuticals Inc.) indication: schizophrenia
2014     NIHR Health Technology Assessment programme Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation
2014     NIHR Horizon Scanning Centre (NIHR HSC) Kangaroo™ feeding tube with IRIS technology for aid in nasogastric tube placement
2014     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Idelalisib (Zydelig(R)) in addition to rituximab for the treatment of relapsed chronic lymphocytic leukaemia
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Azelastine - HCl and fluticasone propionate
2014     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Drug-eluting stents with CD34 antibodies for the treatment of coronary artery disease
2014     NIHR Health Technology Assessment programme Percutaneous vertebroplasty and percutaneous balloon kyphoplasty for the treatment of osteoporotic vertebral fractures: a systematic review and cost-effectiveness analysis
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacoeconomic review report. Lurasidone (Latuda - Sunovion Pharmaceuticals Inc.) indication: schizophrenia
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Urine testing in long-term care: guidelines
2014     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Online programs for weight loss
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Lyophilized plasma for the treatment of adults with hemorrhagic shock: clinical and cost-effectiveness, safety, and guidelines
2014     NIHR Horizon Scanning Centre (NIHR HSC) Aflibercept solution (Eylea) for visual impairment due to macular oedema secondary to branch retinal vein occlusion
2014     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Vasoprotectives: efficacy and safety of capillary stabilising agents for venous insufficiency or haemorrhoids
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Retinal surgeries in non-hospital facilities: clinical and cost-effectiveness
2014     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Sutureless aortic valve replacement in patients with severe aortic valve stenosis
2014     NIHR Horizon Scanning Centre (NIHR HSC) Pertuzumab (Perjeta) for HER2-positive locally advanced, inflammatory or early breast cancer – neo-adjuvant in combination with trastuzumab and docetaxel
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Suboxone versus methadone for the detoxification of patients addicted to prescription opioids: a review of comparative clinical effectiveness, safety, and guidelines
2014     University of York Dementia carers. Effective information, support and services to meet their needs
2014     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Balloon sinuplasty for chronic rhinosinusitus
2014     NIHR Horizon Scanning Centre (NIHR HSC) Pacritinib for myelofibrosis
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Viscosupplementation for the treatment of osteoarthritis of the knee: clinical effectiveness and guidelines
2014     University of York Preventing falls in hospitals
2014     NIHR Horizon Scanning Centre (NIHR HSC) SoftVue™ system for diagnostic breast imaging
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Immediate initiation of continuous positive airway pressure compared with delayed initiation: clinical effectiveness and guidelines
2014     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Implantable carotid sinus baroreflex device for treatment of drug resistant hypertension
2014     NIHR Horizon Scanning Centre (NIHR HSC) Paclitaxel poliglumex (Xyotax) for advanced ovarian cancer – maintenance therapy